highly significantp <0.001
Within both the Prodentis and the placebo groups, with or without SRP, PI, GI, or GBI, the reduction was highly significant ( p <0.001) over the treatment periods ( Fig. 1 ).
Within both the Prodentis and the placebo groups, with or without SRP, PI, GI, or GBI, the reduction was highly significant ( p <0.001) over the treatment periods ( Fig. 1 ).